Latest Breaking News On - Media relations pf pharmaceuticals direction - Page 1 : comparemela.com

Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the Europe Economic Area, UK, and Switzerland. Urovant Sciences

United statesUnited kingdomPierre fabreSumitovant biopharmaJim robinsonMaya frutigerEric ducournauAlana darden powellAnne kerveillantUrovant sciences gmbMedia relations pf pharmaceuticals directionCorporate communicationsPierre fabre groupUrovant sciencesSumitovant biopharma ltdHead of corporate communications